What is Yervoy used for?
What is Yervoy used for?
Please see U.S. Full Prescribing Information and Medication Guide for YERVOY. OPDIVO is a prescription medicine used to treat people with a type of skin cancer called melanoma that has spread or cannot be removed by surgery (advanced melanoma).
How much longer can you live with Opdivo and Yervoy?
According to 6.5 year data from CheckMate-067, median overall survival (OS) for patients with advanced melanoma was 72.1 months with Opdivo plus Yervoy, compared with 36.9 months for patients received Opdivo alone and 19.9 months for Yervoy monotherapy.
How long can you take Yervoy?
For non-small cell lung cancer and pleural mesothelioma, Yervoy is meant to be used as a long-term treatment. If you and your doctor determine that Yervoy is safe and effective for you, you may receive the drug for up to 2 years.
How effective is Yervoy?
In addition a better understanding of significant side effects is becoming clearer. Investigators now report that nearly half the patients who received the Opdivo-Yervoy combination are alive a median of six and a half years after treatment compared to 42% of those treated with Opdivo alone, and 23% with Yervoy alone.
What cancers does Yervoy treat?
Yervoy (ipilimumab) is an immunotherapy drug approved to treat a variety of cancers, including melanoma, kidney cancer, colon cancer, liver cancer, and certain types of lung cancer. It is administered through your vein and may be given alone or in combination with another immunotherapy drug called Optivo (nivolumab).
What is the success rate of Yervoy?
In addition, the Opdivo plus Yervoy combination demonstrated a 6.5-year progression-free survival (PFS) rate of 34% (median of 11.5 months) while PFS rates were 29% (median of 6.9 months) and 7% (median of 2.9 months) for Opdivo alone and Yervoy alone, respectively.
How effective is Opdivo and Yervoy?
OPDIVO + YERVOY TRIAL RESULTS At 28 months, OPDIVO + YERVOY reduced the risk of dying by 45% compared to YERVOY alone. Half of the patients on OPDIVO + YERVOY were alive at 72.1 months, compared to 19.9 months with YERVOY.
How often is YERVOY given?
The recommended dose of YERVOY is 3 mg/kg administered as an intravenous infusion over 90 minutes every 3 weeks for a maximum of 4 doses. In the event of toxicity, doses may be delayed, but all treatment must be administered within 16 weeks of the first dose [see Clinical Studies (14.1)].
How long is YERVOY infusion?
Table 1: Recommended Dosages for YERVOY as a Single Agent
| Indication | Recommended YERVOY Dosage | Duration of Therapy |
|---|---|---|
| Adjuvant treatment of melanoma | 10 mg/kg every 3 weeks followed by 10 mg/kg every 12 weeks (90-minute intravenous infusion) | Every 3 weeks up to a maximum of 4 doses Every 12 weeks for up to 3 years |
Is immunotherapy a last resort for lung cancer?
Today’s immunotherapy is not a cure for late-stage lung cancer. However, it can give certain patients more precious time with family and friends. To provide that, we must carefully select patients who will benefit most and determine the most appropriate available treatment.
What kind of lung cancer does Yervoy treat?
Yervoy is approved as a first-line treatment (in combination with Opdivo) of metastatic non-small cell lung cancer in adults whose tumors express the PD-L1 protein but not any mutations in the epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) genes.
When do you take Yervoy for melanoma?
Yervoy is often given when the cancer has spread to other parts of the body, or cannot be surgically removed, or has come back after prior treatment. Yervoy may prevent melanoma from coming back after surgery, including lymph node removal surgery.
When to use Yervoy as an adjunctive treatment?
Yervoy is also approved as an adjunctive (additional) treatment in patients who have undergone complete resection (removal of the cancer), including total lymphadenectomy (lymph node removal).
Are there any side effects to taking Yervoy?
When Yervoy is taken in combination with Opdivo, additional side effects include: When Yervoy is taken in combination with Opdivo and platinum chemotherapy, additional side effects include: When Yervoy is taken at the higher 10 mg/kg dose (used sometimes to treat melanoma), additional side effects include:
